ALTAMIN LIMITED — Director's Dealing 2021

May 18, 2021

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Alta Zinc Limited
ABN	63 078 510 988

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Geraint Harris
Date of last notice	7 September 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Not applicable
Date of change	19 May 2021
No. of securities held prior to change	80,344,298 fully paid ordinary shares 15,000,000 unlisted options vesting 16 March 2020, exercisable at $0.008 per ordinary shares expiring 16 September 2024 15,000,000 unlisted options vesting 16 September 2020, exercisable at $0.012 per ordinary shares expiring 16 September 2024 15,000,000 unlisted options vesting 16 March 2021, exercisable at $0.016 per ordinary shares expiring 16 September 2024 10,833,333 listed options exercisable at $0.01 per ordinary share expiring 31 January 2022

• See chapter 19 for defined terms.

Appendix 3Y Page 1

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Class	Fully paid ordinary shares (Shares)
Number acquired	20,000,000 fully paid ordinary shares
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$100,000
No. of securities held after change	100,344,298 fully paid ordinary shares 15,000,000 unlisted options vesting 16 March 2020, exercisable at $0.008 per ordinary shares expiring 16 September 2024 15,000,000 unlisted options vesting 16 September 2020, exercisable at $0.012 per ordinary shares expiring 16 September 2024 15,000,000 unlisted options vesting 16 March 2021, exercisable at $0.016 per ordinary shares expiring 16 September 2024 10,833,333 listed options exercisable at $0.01 per ordinary share expiring 31 January 2022
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Shares issued pursuant to Placement as approved at General Meeting of shareholders 18 May 2021

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	Not Applicable
If prior written clearance was provided, on what date was this provided?	Not Applicable

19 May 2021

• See chapter 19 for defined terms.

Appendix 3Y Page 3

01/01/2011